Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study

References

• Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis a systematic review. JAMA 2016;315:2442–58.
   PubMed Web of Science ®Google Scholar
• Horton BT, Magath TB, Brown GE. Arteritis of the temporal vessels: a previously undescribed form. Arch Intern Med 1934;53:400–9.
   Google Scholar
• Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 2017;13:578–92.
   PubMed Web of Science ®Google Scholar
• Nesher G. The diagnosis and classification of giant cell arteritis. J Autoimmun 2014;48–49:73–5.
   PubMed Web of Science ®Google Scholar
• Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311–17.
   PubMed Web of Science ®Google Scholar
• Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 2015;54:463–70.
   PubMed Web of Science ®Google Scholar
• Gribbons KB, Ponte C, Craven A, Robson JC, Suppiah R, Luqmani R, et al. Diagnostic assessment strategies and disease subsets in giant cell arteritis: data from an international observational cohort. Arthritis Rheumatol 2020;72:667–76.
   PubMed Web of Science ®Google Scholar
• de Boysson H, Liozon E, Espitia O, Daumas A, Vautier M, Lambert M, et al. Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis. J Autoimmun 2019;103:102283.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43.
   PubMed Web of Science ®Google Scholar
• Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 2016;20:1–238.
   PubMed Web of Science ®Google Scholar
• Puppo C, Massollo M, Paparo F, Camellino D, Piccardo A, Shoushtari Zadeh Naseri M, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-Fluorodeoxyglucose positron emission tomography. Biomed Res Int 2014;2014:574248.
   PubMed Web of Science ®Google Scholar
• Ironi G, Tombetti E, Napolitano A, Campolongo M, Fallanca F, Incerti E, et al. Diffusion-weighted magnetic resonance imaging detects vessel wall inflammation in patients with giant cell arteritis. JACC Cardiovasc Imaging 2018;11:1879–82.
   PubMed Web of Science ®Google Scholar
• Sugihara T, Hasegawa H, Uchida HA, Yoshifuji H, Watanabe Y, Amiya E, et al. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions. Arthritis Res Ther 2020;7:72.
   Web of Science ®Google Scholar
• Prieto-González S, Arguis P, García-Martínez A, Espígol-Frigolé G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71:1170–16.
   PubMed Web of Science ®Google Scholar
• Vautier M, Dupont A, de Boysson H, Comarmond C, Mirault T, Mekinian A, et al. Prognosis of large vessel involvement in large vessel vasculitis. J Autoimmun 2020;108:102419.
   PubMed Web of Science ®Google Scholar
• Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79:19–30.
   PubMed Web of Science ®Google Scholar
• Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–8.
   PubMed Web of Science ®Google Scholar
• Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017;377:317–28.
   PubMed Web of Science ®Google Scholar
• Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730–6.
   PubMed Web of Science ®Google Scholar
• Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms. J Vasc Surg 1991;13:452–8.
   PubMed Web of Science ®Google Scholar
• Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Care. Diabetes Care 2020;43(Suppl 1):S14–S31.
   Web of Science ®Google Scholar
• Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford) 2008;47:1406–8.
   PubMed Web of Science ®Google Scholar
• Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology (Oxford) 2018;57(Suppl 2):ii22–ii31.
   Web of Science ®Google Scholar
• Zenone T, Puget M. Dry cough is a frequent manifestation of giant cell arteritis. Rheumatol Int 2013;33:2165–8.
   PubMed Web of Science ®Google Scholar
• de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, et al. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 2018;17:391–8.
   PubMed Web of Science ®Google Scholar
• Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging 2018;45:1119–28.
   PubMed Web of Science ®Google Scholar